Bio Works Technologies Ab Stock Earnings Per Share
| BIOWKS Stock | SEK 0.88 0.01 1.12% |
Bio Works Technologies AB fundamentals help investors to digest information that contributes to Bio Works' financial success or failures. It also enables traders to predict the movement of Bio Stock. The fundamental analysis module provides a way to measure Bio Works' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Bio Works stock.
Bio |
Bio Works Technologies AB Company Earnings Per Share Analysis
Bio Works' Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.
Current Bio Works Earnings Per Share | (0.41) X |
Most of Bio Works' fundamental indicators, such as Earnings Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bio Works Technologies AB is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Earnings per Share is one of the most critical measures of the firm's current share price and is used by investors to determine the overall company profitability, especially when compared to the EPS of similar companies.
| Competition |
According to the company disclosure, Bio Works Technologies AB has an Earnings Per Share of -0.415 times. This is 104.96% lower than that of the Healthcare sector and 91.34% lower than that of the Biotechnology industry. The earnings per share for all Sweden stocks is 113.3% higher than that of the company.
Bio Earnings Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Bio Works' direct or indirect competition against its Earnings Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Bio Works could also be used in its relative valuation, which is a method of valuing Bio Works by comparing valuation metrics of similar companies.Bio Works is currently under evaluation in earnings per share category among its peers.
Bio Fundamentals
| Return On Equity | -0.66 | |||
| Return On Asset | -0.35 | |||
| Profit Margin | (1.31) % | |||
| Operating Margin | (1.27) % | |||
| Current Valuation | 635.01 M | |||
| Shares Outstanding | 34.87 M | |||
| Shares Owned By Insiders | 54.85 % | |||
| Shares Owned By Institutions | 5.59 % | |||
| Price To Book | 8.03 X | |||
| Price To Sales | 19.71 X | |||
| Revenue | 21.91 M | |||
| Gross Profit | 53.01 M | |||
| EBITDA | (8.6 M) | |||
| Net Income | (12.94 M) | |||
| Cash And Equivalents | 46.35 M | |||
| Cash Per Share | 2.40 X | |||
| Current Ratio | 9.14 X | |||
| Book Value Per Share | 2.55 X | |||
| Cash Flow From Operations | (13.37 M) | |||
| Earnings Per Share | (0.41) X | |||
| Target Price | 27.0 | |||
| Number Of Employees | 36 | |||
| Beta | 0.99 | |||
| Market Capitalization | 718.4 M | |||
| Total Asset | 120.86 M | |||
| Net Asset | 120.86 M |
About Bio Works Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Bio Works Technologies AB's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Bio Works using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Bio Works Technologies AB based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Bio Stock
Bio Works financial ratios help investors to determine whether Bio Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Bio with respect to the benefits of owning Bio Works security.